- AuthorisedTherapeutic exploratory (Phase II)
STING - Maintenance or withdrawal of urate lowering therapy according to ultrasound features in gout patients: a randomised controlled trial
This study looks at whether people with gout can stop their uric acid-lowering medicine or need to keep taking it. Researchers will watch if stopping treatment leads to more gout attacks, using scans and checking symptoms.
For: Gout adult patientsFrance - AuthorisedTherapeutic exploratory (Phase II)
A multi-center single arm Phase II study to evaluate the safety and efficacy of genetically engineered autologous cells expressing anti-CD20 and anti-CD19 specific chimeric antigen receptor in subjects with relapsed and/or refractory diffuse large B cell lymphoma
This study looks at a new type of cell therapy, called MB-CART2019.1, for people with a specific type of lymphoma that has come back or hasn't responded to other treatments. It checks how safe and effective it is.
For: Relapsed/refractory diffuse large B cell lymphoma (R-R DLBCL)Hungary · Croatia - Ongoing, recruitingTherapeutic use (Phase IV)
GOut TrEatment STrategy (GO TEST) FINALE study, a multicentre pragmatic randomized superiority trial of continuation versus cessation of urate lowering therapies in gout in remission.
This study, called GO TEST FINALE, is looking into the best way to manage gout. If your gout is under control, doctors want to know if it's better to keep taking your gout medication or if you can safely stop. They will compare different treatments over two years.
For: GoutNetherlands